Jade Biosciences, Inc.
Nasdaq JBIO · Waltham, MA
Works in Renal & urogenital · Women's health
Jade Biosciences, Inc. is a clinical trial sponsor based in Waltham, MA, listed as Nasdaq JBIO. It has 4 active clinical trials with 138 planned participants, in Renal & urogenital and Women's health.
Trial track record · since 2021
Financials · Nasdaq JBIO
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Jade Biosciences, Inc
Jade Biosciences, Inc is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 138 planned participants, in Renal & urogenital, Women's health. Since 2021 it has completed 0 trials and stopped 0 early.
Jade Biosciences, Inc is based in Waltham, MA and is listed as Nasdaq JBIO. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Jade Biosciences, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-25.
Approve Suite is not affiliated with Jade Biosciences, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.